background image

Healthcare Funds

Piper Heartland Healthcare Capital, LLC

Piper Heartland Healthcare Capital aligns the knowledge, expertise and capital of Piper Sandler with the interests of our limited partners to invest in innovative healthcare companies at key moments in their growth path. This combination—knowledge, expertise, capital and alignment—allows Piper Heartland Healthcare Capital to pursue proprietary investment opportunities and deliver exceptional potential returns for investors.

Flagship Fund: The Piper Heartland Healthcare Crossover Fund

The Piper Heartland Healthcare Crossover Fund is a dedicated healthcare investment platform with over $200 million in committed capital, that focuses on innovative companies with near-term public markets prospects, driven by experienced management teams and backed by highly respected investment partners.

Building on the industry knowledge and capital markets expertise of Piper Sandler’s leading healthcare banking and research platforms, the Piper Heartland Healthcare Crossover Fund invests primarily in biotech, med-tech and healthcare information sectors.

Read the press release announcing the final closing of the fund.

Image
FW - Healthcare 1

Piper Heartland Healthcare Capital Strategy

1. Access to the Leading Piper Sandler Healthcare Platform
  • Proprietary Deal Flow: Exclusive access to Piper Sandler healthcare relationships
  • Market Insights: Leader in healthcare capital markets & growth-stage M&A
  • Research Capabilities: Unrivaled access to Piper Sandler equity research professionals
2. Unique Approach to Participating in Investor Syndicates
  • Don’t Lead Deals: To avoid conflicts of interest with clients of the firm
  • Flexible Investment Sizes: Matching each situation leading to inclusion
  • Portfolio Advisory: Lend Wall Street experience to provide unbiased and aligned counsel on financing and strategic decisions 
3. Portfolio Designed to Deliver Alpha Across Cycles
  • Broad Exposure to Growth Healthcare Verticals: Flexibility to invest across biotech, Med-Tech and HCIT as sector-wide challenges and opportunities emerge
  • Optimal Fund Size: Capital base designed to support curated portfolio that balances diversification with selective concentration
     

Piper Sandler Healthcare Platform

Piper Sandler & Co. has been a leading strategic adviser in healthcare investment banking and underwriting for over 30 years. In addition to strategic and capital advisory services, Piper Sandler serves clients through an award-winning research platform, which publishes macro-economic, industry and company-specific research.

300+

Bookrun public equity financings representing over $40 billion in capital*

250+

Companies covered across all major healthcare subsectors by 12 senior research analysts

*As of 2010, healthcare companies


Current and Past Investments

Since inception, Piper Heartland Healthcare Capital has invested in the following companies:

Alumis

Antios

Arbor

Artios

https://www.avalynpharma.com/

Bicara

Boundless Bio

Cargo

Cleerly

Endeavor

Maze

Maze

ProfoundBio

Shoreline

Structure

Sonoma


The Piper Heartland Healthcare Capital Strategy provides investment advisory services through the registered investment adviser, Piper Heartland Healthcare Capital, LLC.